Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status

NCT06356714 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Neoplasms

Interventions

DRUG: Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens

Sponsor

Sun Jing